ES2126660T3 - Proceso para la preparacion de cristales de hormona del crecimiento y los cristales asi obtenidos. - Google Patents

Proceso para la preparacion de cristales de hormona del crecimiento y los cristales asi obtenidos.

Info

Publication number
ES2126660T3
ES2126660T3 ES93924266T ES93924266T ES2126660T3 ES 2126660 T3 ES2126660 T3 ES 2126660T3 ES 93924266 T ES93924266 T ES 93924266T ES 93924266 T ES93924266 T ES 93924266T ES 2126660 T3 ES2126660 T3 ES 2126660T3
Authority
ES
Spain
Prior art keywords
crystals
pct
date
alkyl
growth hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93924266T
Other languages
English (en)
Inventor
Ebba Florin-Robertsson
Elvy Hokby
Ronny Lundin
Sirkka Thome
Gertrud Westin-Sjodahl
Tomas Lundqvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9203175A external-priority patent/SE9203175D0/xx
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Application granted granted Critical
Publication of ES2126660T3 publication Critical patent/ES2126660T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

EL INVENTO SE REFIERE A UN PROCESO PARA FABRICAR CRISTALES DE HORMONA DEL CRECIMIENTO (GH) O DERIVADOS FUNCIONALES DE LA MISMA CARACTERIZADO POR LOS PASOS DE: (I) MEZCLAR GH O DERIVADOS FUNCIONALES DE LA MISMA CON UNA SOLUCION ACUOSA QUE COMPRENDE UN AMORTIGUADOR Y UN COMPUESTO QUIMICO CON LA FORMULA GENERAL (I): AR - [ - CR1R2 - ]N - [ - CR3R4 - ]M - CR5R6 - OH EN LA QUE AR ES FENILO, FENILO SUBSTITUIDO ALQUILO, NAFTILO, NAFTILO SUBSTITUIDO ALQUILO, R1 A R6 ES H, OH O ALQUIL Y N Y M SON 0 O 1; (II) INCUBAR LA MEZCLA; (III) AISLAR LOS CRISTALES POR METODOS CONOCIDOS. TAMBIEN SE REFIERE AL EMPLEO DEL COMPUESTO QUIMICO CON LA FORMULA GENERAL (I) EN LA PREPARACION DE CRISTALES DE GH A PARTIR DE UNA SOLUCION AMORTIGUADORA, CRISTALES DE HORMONA DEL CRECIMIENTO O CUALQUIER ANALOGO FUNCIONAL DE LOS MISMOS EN FORMA DE AGUJAS, FORMAS TETRAGONALES, CUBOS O PARALELEPIPEDOS CON UNA LONGITUD DE AL MENOS 20 MICRONES, Y SUSPENSIONES PARA LA INYECCION, FORMULACIONES DE DEPOSITO Y FORMULACIONES EN SECO QUECONTIENEN LOS CRISTALES.
ES93924266T 1992-10-28 1993-10-27 Proceso para la preparacion de cristales de hormona del crecimiento y los cristales asi obtenidos. Expired - Lifetime ES2126660T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9203175A SE9203175D0 (sv) 1992-10-28 1992-10-28 Growth hormone
SE19939302278A SE9302278D0 (sv) 1992-10-28 1993-07-02 Growth hormone

Publications (1)

Publication Number Publication Date
ES2126660T3 true ES2126660T3 (es) 1999-04-01

Family

ID=26661557

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93924266T Expired - Lifetime ES2126660T3 (es) 1992-10-28 1993-10-27 Proceso para la preparacion de cristales de hormona del crecimiento y los cristales asi obtenidos.

Country Status (14)

Country Link
US (1) US5734026A (es)
EP (1) EP0669934B1 (es)
JP (1) JP3470135B2 (es)
AT (1) ATE174602T1 (es)
AU (1) AU679012B2 (es)
CA (1) CA2147482C (es)
DE (1) DE69322654T2 (es)
DK (1) DK0669934T3 (es)
ES (1) ES2126660T3 (es)
FI (1) FI110609B (es)
HK (1) HK1013299A1 (es)
NO (1) NO320171B1 (es)
SE (1) SE9302278D0 (es)
WO (1) WO1994010192A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
DE69839563D1 (de) 1997-09-05 2008-07-10 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle
US6380357B2 (en) * 1997-12-16 2002-04-30 Eli Lilly And Company Glucagon-like peptide-1 crystals
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
KR20040085205A (ko) * 2002-02-20 2004-10-07 일라이 릴리 앤드 캄파니 Ｇｌｐ-1 분자의 투여 방법
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
RU2357750C2 (ru) 2002-12-31 2009-06-10 Элтус Фармасьютикалз Инк. Кристаллы человеческого гормона роста и способы их получения
US20060286129A1 (en) * 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
AU2006330833A1 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69125035T2 (de) * 1990-06-04 1997-07-10 Schering Corp Verfahren zur herstellung von interferon-alpha-2 kristallen
IL98484A0 (en) * 1990-06-15 1992-07-15 Schering Corp Crystalline interleukin-4
DK168790D0 (es) * 1990-07-13 1990-07-13 Novo Nordisk As
US5015627A (en) * 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone

Also Published As

Publication number Publication date
DE69322654D1 (de) 1999-01-28
FI952021A (fi) 1995-04-27
ATE174602T1 (de) 1999-01-15
SE9302278D0 (sv) 1993-07-02
NO320171B1 (no) 2005-11-07
CA2147482C (en) 2003-09-23
DK0669934T3 (da) 1999-08-23
CA2147482A1 (en) 1994-05-11
NO951547D0 (no) 1995-04-24
HK1013299A1 (en) 1999-08-20
JP3470135B2 (ja) 2003-11-25
WO1994010192A1 (en) 1994-05-11
US5734026A (en) 1998-03-31
AU5401194A (en) 1994-05-24
DE69322654T2 (de) 1999-06-17
AU679012B2 (en) 1997-06-19
EP0669934B1 (en) 1998-12-16
JPH08505127A (ja) 1996-06-04
EP0669934A1 (en) 1995-09-06
FI952021A0 (fi) 1995-04-27
FI110609B (fi) 2003-02-28
NO951547L (no) 1995-04-24

Similar Documents

Publication Publication Date Title
ES2126660T3 (es) Proceso para la preparacion de cristales de hormona del crecimiento y los cristales asi obtenidos.
KR860002958A (ko) 살균제의 제법
DE69503604D1 (de) Stabilisierte orthokieselsäure enthaltende zubereitung sowie biologische zubereitung
CA2031766A1 (en) 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insecticides and acaricides containing the same
HUT36784A (en) Process for producing spasmolytic sulfanate derivatives and pharmaceutical compositions containing them as active agents
SE9502244D0 (sv) A composition and a process for the preparation thereof
KR870006016A (ko) N-벤조일 우레아 화합물, 이를 함유하는 항종양 조성물 및 그의 제조 방법
DK0697019T3 (da) Risperidon pamoater
MX164474B (es) PROCEDIMIENTO PARA EL CRECIMIENTO DE CRISTAL DE MTiOXO4 DE UNA SOLUCION
ES2060399T3 (es) Cristales de la hormona del crecimiento y procedimiento para la produccion de estos cristales de la hormona del crecimiento.
ES2032958T3 (es) Agente reductor mejorado y metodo para la deposicion no electrolitica de plata.
JPS567716A (en) Preventive and remedy for cerebral angiospasm
YU46699B (sh) Kristalni monohidratni oblik 1-karbacefalosporina
ES2043070T3 (es) Procedimiento para la preparacion de derivados de la benzotiazolamina-2.
IT1243801B (it) Intermedi per agenti chelanti con simmetria prefissata, e procedimentoper la loro preparazione
PT99669A (pt) Processo para a preparacao de composicoes nematodicidas contendo como ingrediente activo 2r,5r-di-hidroximetil-3r,4r-di-hidroxipirrolidina (dmdp) como ingrediente activo
DE69232980D1 (de) Pyrroloazepinderivate
ES557597A0 (es) Procedimiento para preparar acidos hexenoicos
UY25861A1 (es) Retinamidas del acido 7-aril-6-(z) heptatrienico
UA66832C2 (uk) Термодинамічно стійка модифікація і рематробану, спосіб одержання затравочних кристалів, спосіб одержання термодинамічно стійкої форми раматробану та фармацевтична композиція
Magnarelli Resorption of retained eggs and follicular degeneration in mosquitoes (Diptera: Culicidae)
GB1513840A (en) Phenoxycarboxylic acid aryloxy(thio)-carbonylaminomethyl esters and their use for regulating plant growth
ES8407028A1 (es) Un compuesto de imidazolilpropanol opticamente activo.
ES2032438T3 (es) Procedimiento para la preparacion de acido 6,7-dihidro-5,8-dimetil-9-fluor-1-oxo-1h,5h-benzo(i,j)quinolizina-2-carboxilico.
SE8106300L (sv) Medel i synnerhet for bladfellning pa plantor

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 669934

Country of ref document: ES